Treating Asymmetric Eyebrows and Facial Imbalances with Precision Injections

In select cases where brow asymmetry results primarily from differences in the muscle activity patterns between the two sides of the face, carefully placed muscle relaxing injections may help reduce the degree of visible asymmetry. This is achieved by selectively modulating the activity of muscles contributing to asymmetric positioning on the more dominant side. The degree of improvement achievable is modest and individual, and this approach is not appropriate for all types of brow asymmetry.

Facial asymmetry refers to any difference in the appearance of one side of the face compared to the other. In the context of the eyebrows, this may manifest as one brow sitting perceptibly higher or lower than the other, a difference in the arch shape or peak position, or a difference in how the brows respond to facial expressions.

The causes of brow asymmetry are varied. Naturally, there is inherent skeletal and soft tissue asymmetry in virtually all human faces — the underlying bones, fat pads, and soft tissue volumes differ between sides to some degree. This structural asymmetry cannot be addressed by injectable treatment alone.

Muscle activity asymmetry is a separate and potentially more relevant factor for injectable treatment. If the muscles on one side of the face are habitually more active — whether due to dominant expression patterns, previous injury, compensatory movements, or other factors — this can result in differential dynamic wrinkling and a difference in resting brow position over time.

Some patients notice that their brow asymmetry is more pronounced after periods of stress or fatigue, or more visible in photographs or video calls. Others have had a noticeable difference for as long as they can remember. Understanding the likely contributing factors helps inform whether injectable treatment is likely to be useful.

The position of the eyebrow at rest is determined by the dynamic interplay between muscles that elevate the brow — primarily the frontalis — and muscles that depress it — the orbicularis oculi, corrugator supercilii, procerus, and depressor supercilii. If these opposing forces are balanced differently between the left and right sides, the resulting resting brow position will differ.

Botulinum toxin works by temporarily reducing acetylcholine release at the neuromuscular junction, thereby reducing the contractile force of the targeted muscle. By strategically reducing the activity of the depressor muscles on the side where the brow sits lower — or by modifying the balance of elevation and depression in the brow region — a skilled practitioner may be able to encourage a degree of brow symmetry.

This is a technique-dependent and anatomy-dependent process. The forehead and periorbital region are among the most anatomically complex areas to treat with injectable muscle relaxing products, as multiple overlapping muscles contribute to brow position and expression. Achieving a meaningful improvement in brow symmetry without creating an unnatural appearance requires detailed anatomical knowledge and precise injection placement.

In clinical practice, a practitioner assessing a patient with brow asymmetry will first seek to understand whether the asymmetry is primarily structural or primarily dynamic in nature. Structural asymmetry — resulting from differences in bone, fat, or skin on the two sides — is unlikely to be significantly improved through muscle relaxing injections alone, and may require a different treatment approach or combination of approaches if the patient wishes to address it.

For asymmetry that has a dynamic or muscle-activity component, a practitioner may discuss the potential to adjust the relative activity of muscles on one or both sides using carefully placed injections. This might involve treating the depressor muscles on the lower-sitting brow side more aggressively, whilst using a more conservative approach on the other side to preserve natural movement.

The results of such an approach are variable and dependent on the individual's anatomy, muscle mass, and the degree of asymmetry. Importantly, the goal is typically to reduce the degree of noticeable difference rather than to achieve perfect symmetry — which is, in any case, not a natural state for the human face. Patients should approach this with realistic expectations and an understanding that outcomes cannot be guaranteed.

Beyond the eyebrow region, injectable treatments are sometimes considered as part of a broader discussion about facial balance. Differential muscle activity across the face can contribute to asymmetric wrinkle patterns, an asymmetric smile, or differences in the apparent size of the masseter muscles on each side — a concern sometimes addressed with muscle relaxing injections to the jaw.

Volume differences between the two sides of the face — affecting cheek projection, nasolabial folds, or other areas — are primarily structural in nature and may be more appropriately addressed through carefully placed dermal filler treatments rather than muscle relaxing injections. A thorough consultation helps identify which type of asymmetry is present and which treatment modality, if any, is most appropriate.

In some cases, the most honest and clinically appropriate advice is that the asymmetry present is within the natural range of variation and that no treatment is indicated. A medically-led practitioner will always prioritise accuracy over commercial motivation.

Patients who have noticed a consistent difference in their brow position or height and who find this affects their confidence or satisfaction with their appearance may find it worthwhile to arrange a professional consultation to explore their options. This is particularly relevant if the asymmetry appears to have worsened over time or is more pronounced on one side during facial movement.

Patients who are concerned about whether their existing muscle relaxing treatment is contributing to, or could be adjusted to help address, asymmetry in the treated area may also benefit from a review appointment with their practitioner.

A consultation should include a thorough assessment of facial anatomy at rest and in motion, a discussion of the likely underlying causes of the asymmetry, and an honest conversation about what injectable treatment can and cannot achieve. For an overview of what this type of appointment involves, see our guide on what to expect at your first aesthetic consultation.

When performed with appropriate skill, knowledge of anatomy, and careful assessment of the individual patient, precision injectable treatment for brow asymmetry can offer a modest reduction in the visible degree of asymmetry. For patients whose brow asymmetry has a significant dynamic component, this can be a meaningful aesthetic improvement.

The limitations of this approach are important to understand clearly. Injectable treatments for asymmetry are entirely temporary — the effects wear off over three to four months as muscle activity returns, and treatments must be repeated to maintain any benefit. Correction is rarely complete, and achieving a degree of improvement on one side can occasionally introduce a subtle change on the other. Individual variation in anatomy means that outcomes are not fully predictable.

Patients should be cautious of any practitioner who promises a specific degree of improvement or who presents brow asymmetry correction as a straightforward procedure. It requires skill, experience, and a thorough understanding of individual facial dynamics. The emphasis should always be on achieving natural-looking results rather than a formulaic approach.

As with all injectable aesthetic treatments, precision injections for facial asymmetry carry potential risks that must be understood as part of the consent process. In addition to the common side effects applicable to all injectable treatments — bruising, temporary swelling, and injection site tenderness — the brow and periorbital region carries some specific risks.

Over-treatment of the frontalis or incorrect placement in the forehead region can result in brow heaviness or, in rare cases, temporary lid ptosis (drooping of the upper eyelid). The risk of these outcomes is minimised by working with a practitioner who has detailed anatomical knowledge and who takes a conservative, staged approach to correction.

Botulinum toxin is a prescription-only medicine (POM) in the UK. Treatment requires a face-to-face medical assessment and a valid prescription from a qualified prescriber. Patients should ensure they seek treatment only from appropriately qualified practitioners working within a medically-led environment.

Following any injectable treatment to the brow or periorbital region, standard aftercare applies: avoid rubbing or massaging the treated area for several hours, remain upright for at least four hours after treatment, avoid strenuous exercise and significant heat exposure for 24 to 48 hours, and attend any follow-up appointment scheduled by your practitioner.

A review appointment — typically around two weeks post-treatment — provides an opportunity to assess the degree of asymmetry correction achieved, to identify any areas where fine-tuning may be appropriate, and to discuss the ongoing treatment plan. This iterative approach is often how the best results with asymmetry correction are achieved over time.

Sun protection and a supportive skincare routine are valuable in all patients undergoing facial aesthetic treatments and contribute to the quality of the skin environment in which these treatments perform.